Zoonotic Infections News

WHO Director-General Margaret Chan, MD, declared the ongoing Ebola outbreak in West Africa a public health emergency of international concern, according to a press release.

WHO is convening a panel of medical ethicists to evaluate the use of experimental treatments in the Ebola outbreak, according to a statement.

A monthly dose of dihydroartemisinin-piperaquine was safe and effective in reducing young Ugandan children’s risk for malaria, according to study findings in PLoS Medicine.

The two American patients who contracted the Ebola virus in Liberia have arrived in the United States and are in isolation at Emory University Hospital, according to an Emory press release.

Mass drug administration programs are not sufficient on their own to control schistosomiasis, according to researchers from Griffith Health Institute at Griffith University in Australia.

Artemisinin resistance has developed in Plasmodium falciparum in border regions of Southeast Asia, according to a report in The New England Journal of Medicine.

Chikungunya virus has, quite unexpectedly and quickly, taken the Caribbean by storm. The first case in the region was reported in mid-December among residents of the French side of Saint Martin. It was the first time the virus was identified among non-travelers in the Western Hemisphere.

A research team from Saudi Arabia detected Middle East respiratory syndrome, or MERS, coronavirus in air samples taken from a barn that sheltered a camel infected with the virus, according to new data published in mBio.

The NIH has awarded a 3-year, $420,000 grant to a research team at Worcester Polytechnic Institute in Massachusetts to test a plant-based therapy for malaria that has been in use for thousands of years, according to the university.

The CDC today confirmed the first autochthonous case of chikungunya virus infection in the United States. The case was reported in a man in Florida who had no recent travel history.